GlycoMimetics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.15 | $35.46 M | -0.78 | 22 |
MLYS
Mineralys Therapeutics, Inc. |
$15.84 | $1.03 B | -4.28 | 51 |
BCAB
BioAtla, Inc. |
$0.39 | $22.76 M | -0.32 | 61 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 |
FHTX
Foghorn Therapeutics Inc. |
$4.30 | $239.97 M | -3.34 | 112 |
DYN
Dyne Therapeutics, Inc. |
$11.76 | $1.34 B | -3.26 | 192 |
CUE
Cue Biopharma, Inc. |
$0.63 | $47.16 M | -0.98 | 41 |
ASMB
Assembly Biosciences, Inc. |
$13.76 | $105.32 M | -2.22 | 73 |
SPRO
Spero Therapeutics, Inc. |
$2.35 | $131.39 M | -1.84 | 32 |
TIL
Instil Bio, Inc. |
$26.75 | $176.10 M | -2.24 | 14 |
TRVI
Trevi Therapeutics, Inc. |
$6.26 | $636.92 M | -13.91 | 31 |
ACHL
Achilles Therapeutics plc |
$0.00 | $60.83 M | -0.89 | 204 |
IVA
Inventiva S.A. |
$3.29 | $317.23 M | -0.87 | 114 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
